New Search Search History

Holdings Information

    Manual of clinical psychopharmacology / Alan F. Schatzberg, M.D., Kenneth t. Norris, Jr. Professor, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, Charles DeBattista, D.M.H., M.D., Professor of Psychiatry and Behavioral Sciences, Co-Director, Depression Research Clinic and Research Program, Director, Mood Disorders Center, Director, Medical Student Education in Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.

    • Title:Manual of clinical psychopharmacology / Alan F. Schatzberg, M.D., Kenneth t. Norris, Jr. Professor, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, Charles DeBattista, D.M.H., M.D., Professor of Psychiatry and Behavioral Sciences, Co-Director, Depression Research Clinic and Research Program, Director, Mood Disorders Center, Director, Medical Student Education in Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
    •    
    • Author/Creator:Schatzberg, Alan F., author.
    • Other Contributors/Collections:DeBattista, Charles, author.
    • Published/Created:Washington, DC : American Psychiatric Publishing, a division of American Psychiatric Association, [2015]
      ©2015
    • Holdings

       
    • Library of Congress Subjects:Psychopharmacology--Handbooks, manuals, etc.
      Psychotropic drugs--Handbooks, manuals, etc.
    • Medical Subjects: Psychopharmacology--methods.
      Psychotropic Drugs--pharmacology.
      Mental Disorders--drug therapy.
    • Genre/Form:Handbooks and manuals.
    • Edition:Eighth edition.
    • Description:xxiii, 771 pages : illustrations ; 21 cm
    • Summary:For nearly 30 yeras, the Manual of Clinical Psychopharmacology has been the preeminent volume on psychotropic medications and the go-to source for psychiatrists prescribing for their patients and for students in psychiatry and pharmacology. This new, eighth edition has been thoroughly updated in recognition of the relentless developments in the field, including the release of new U.S. Food and Drug Administration - approved drugs, newly approved uses for existing drugs, and newly identified interactions, dosing guidelines, and documented side effects. As with previous iterations, this edition is logically structured and highly readable. However, the ever-expanding number of available agents and indications mandated the condensing of some sections and the elimination of others to keep the book from becoming too large to be user-friendly. The resulting volume is DSM-5 compatible, easy-to-use, and practical, with summary tables for quick reference. -- from back cover.
    • Notes:Includes bibliographical references and index.
    • ISBN:9781585624812 (pbk. ; alk. paper)
      1585624810 (pbk. ; alk. paper)
    • Contents:Machine generated contents note: General Advice
      Practice Guidelines
      Legal, Ethical, and Economic Issues
      Bibliography
      Overall Organization of DSM-5
      Neurodevelopmental Disorders
      Schizophrenia Spectrum and Other Psychotic Disorders
      Mood Disorders
      Bipolar and Related Disorders
      Depressive Disorders
      Anxiety Disorders
      Obsessive-Compulsive and Related Disorders
      Trauma- and Stressor-Related Disorders
      Somatic Symptom and Related Disorders
      Personality Disorders
      Substance Use Disorders
      Feeding and Eating Disorders
      FDA Approval of Symptom Reduction Strategies
      DSM-5 and Pharmacogenetics
      Summary
      Bibliography
      History
      General Principles of Antidepressant Use
      Choosing an Antidepressant
      Dosage and Administration
      Duration of Treatment
      Selective Serotonin Reuptake Inhibitors
      Pharmacological Effects
      Indications
      Side Effects
      Overdose
      Drug Interactions
      Dosage and Administration
      Discontinuation
      Serotonin-Norepinephrine Reuptake Inhibitors (Venlafaxine, Desvenlafaxine, Duloxetine, Levomilnacipran, and Milnacipran)
      Pharmacological Effects
      Indications
      Side Effects
      Overdose
      Drug Interactions
      Dosage and Administration
      Discontinuation
      5-HT2 Receptor Antagonists (Trazodone and Nefazodone)
      Pharmacological Effects
      Indications
      Side Effects
      Overdose
      Drug Interactions
      Dosage and Administration
      Discontinuation
      Combined Noradrenergic-Dopaminergic Antidepressant (Bupropion)
      Pharmacological Effects
      Indications
      Side Effects
      Overdose
      Drug Interactions
      Dosage and Administration
      Mirtazapine
      Pharmacological Effects
      Indications
      Side Effects
      Overdose
      Drug Interactions
      Dosage and Administration
      Vilazodone
      Vortioxetine
      Tricyclic and Tetracyclic Antidepressants
      Structures
      Pharmacological Effects
      Indications
      Blood Levels
      Side Effects
      Overdose
      Dosage and Administration
      Discontinuation
      Monoamine Oxidase Inhibitors
      Pharmacological Effects
      Indications
      Side Effects
      Overdose
      Drug Interactions
      Dosage and Administration
      Discontinuation
      Selective and Reversible Monoamine Oxidase Inhibitors
      Norepinephrine Reuptake Inhibitors: Reboxetine and Atomoxetine
      Pharmacological Effects
      Indications
      Side Effects
      Overdose
      Dosage and Administration
      Drug Interactions
      Discontinuation
      Novel and Evolving Antidepressant Agents
      Bibliography
      General Principles of Antipsychotic Use
      Drugs
      Efficacy
      Acute Antipsychotic Treatment
      Early Intervention in First-Episode Psychosis
      Inpatient Treatment
      Maintenance Drug Therapy
      Use in Other Psychiatric Disorders
      Second-Generation (Atypical) Antipsychotics
      Clozapine
      Risperidone
      Paliperidone
      Iloperidone
      Olanzapine
      Quetiapine
      Ziprasidone
      Aripiprazole
      Lurasidone
      Asenapine
      First-Generation (Typical) Antipsychotics
      Side Effects
      Long-Acting Injectable Antipsychotics
      Adjunctive Treatment of Negative and Cognitive Symptoms
      Alternatives to Antipsychotic Therapy
      Antipsychotic Drugs Newly Released or in Development.
      Bibliography
      General Treatment Approaches
      Acute Mania
      Acute Bipolar Depression
      Maintenance Therapy
      Rapid-Cycling Bipolar Disorder
      Mixed States
      Lithium
      History and Indications
      Pharmacological Effects
      Clinical Indications
      Side Effects
      Preparations
      Dosage and Administration
      Use in Pregnancy
      Anticonvulsants
      Valproate
      Carbamazepine
      Lamotrigine
      Other Anticonvulsants
      Gabapentin and Pregabalin
      Topiramate
      Tiagabine
      Oxcarbazepine
      Levetiracetam, Zonisamide, and Ethosuximide
      Antipsychotics
      Benzodiazepines
      Calcium Channel Blockers
      Omega-3 Fatty Acids
      Bibliography
      Benzodiazepines
      Indications
      Pharmacological Effects
      Subclasses
      Dosage and Administration
      Withdrawal
      Side Effects
      Overdose
      Antidepressants
      Agoraphobia and Panic
      Generalized Anxiety Disorder
      Social Anxiety Disorder
      Posttraumatic Stress Disorder
      Obsessive-Compulsive Disorder
      Anticonvulsants
      Antipsychotics
      Noradrenergic Agents
      Clinical Indications
      Dosage and Administration
      Side Effects
      Antihistamines
      Buspirone
      Novel Anxiolytic Agents
      Bibliography
      Insomnia
      Behavioral Approaches
      Pharmacological Approaches
      Benzodiazepine Hypnotics
      Nonbenzodiazepine Hypnotics
      Melatonin Receptor Agonists: Ramelteon and Tasimelteon
      Sedative Antihistamines and Other Nonbenzodiazepine Psychoactive Drugs With Hypnotic Properties
      Other Hypnotics
      Dual Orexin Receptor Antagonists
      General Conclusions
      Bibliography
      Amphetamine Abuse
      Uses of Stimulants
      Attention-Deficit/Hyperactivity Disorder
      Depression
      Acquired Immunodeficiency Syndrome
      Binge-Eating Disorder
      Other Medical Conditions
      Drug Combinations
      Psychosis
      Stimulant Use Versus Abuse
      Atomoxetine
      Guanfacine
      Other Fast-Acting Drugs
      Bibliography
      Augmentation Strategies for Depression
      Lithium-Antidepressant Combinations
      Thyroid Supplement[
      ]Antidepressant Combinations
      Estrogen, DHEA, and Testosterone Combinations With Antidepressants
      Dopamine Agonist[
      ]Antidepressant Combinations
      Monoamine Precursor[
      ]Antidepressant Combinations
      SSRI Combinations
      Antipsychotic-Antidepressant Combinations
      Other TCA Combinations
      Augmentation/Combination Strategies for Bipolar Disorder
      Combinations of Two or More Mood Stabilizers
      Mood Stabilizer[
      ]Antipsychotic Combinations
      Mood Stabilizer[
      ]Antidepressant Combinations
      Mood Stabilizers and Omega-3 Fatty Acids
      Augmentation Strategies for Schizophrenia
      Combinations of Two Antipsychotics
      Combinations of Antidepressants and Antipsychotics
      Combinations of Mood Stabilizers and Antipsychotics
      Other Augmentation Strategies
      Bibliography
      Agitation and Violence
      Depression and Suicidality
      Acute Psychotic Episodes
      Mixed Psychotic Features
      Schizophrenic, Schizophreniform, and Manic Psychoses
      Delirium
      Severe Anxiety
      Stupor and Catatonia
      Emergency Department Referrals
      Bibliography
      Drug Testing
      Stimulants
      Opiates
      Detoxification
      Maintenance
      Sedatives and Hypnotics
      Detoxification
      Benzodiazepines
      Alcohol
      Detoxification
      Maintenance Treatment
      Nicotine
      Cannabis
      Hallucinogens
      Phencyclidine
      Bibliography
      Pregnancy
      Pediatric Psychopharmacology
      Stimulants
      Antipsychotics
      Antidepressants
      Mood Stabilizers
      Antianxiety Drugs
      Geriatric Psychopharmacology
      Antidepressants
      Hypnotics and Anxiolytics
      Mood Stabilizers
      Antipsychotics
      Medications for Dementia
      Medications for Agitation
      Intellectual Disability
      Medical Conditions
      Psychiatric Disorders Resulting From Medical Illness
      Psychiatric Disorders Associated With Nonpsychiatric Drugs
      Psychiatric Disorders Complicated by Medical Disorders
      Conclusion
      Bibliography.
    Session Timeout
    New Session